Rodrigo Galhardi Gasparini

3PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 16, 2025
Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Jul 18, 2025
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Jun 01, 2022
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).

Ligia Yukie Sassaki, Daniela Oliveira Magro, Rogerio Saad-Hossne

Pageof 1

Frequent Collaborators

3 joint publications

Cristina Flores

3 joint publications

Carlos Henrique Marques Dos Santos

2 joint publications

Bianca Loyo Pona Schiavetti

2 joint publications

Rogério Serafim Parra